Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biopharmaceutics and Interpharm

Executive Summary

Former VP Abu Quamruzzaman sentenced to nine months in prison in Baltimore federal court Oct. 14. Quamruzzaman pled guilty in July to submitting false information on Biopharmaceutic's ANDA for clindamycin 150 mg capsules; he also filed false data in Interpharm ANDAs. Biopharmaceutics pled guilty in July to submission of false information to FDA ("The Pink Sheet" July 12, T&G-13).
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS023538

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel